CLYMB CLINICAL Trademark

Trademark Overview

On Tuesday, October 11, 2022, a trademark application was filed for CLYMB CLINICAL with the United States Patent and Trademark Office. The USPTO has given the CLYMB CLINICAL trademark a serial number of 97627417. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, July 10, 2025. This trademark is owned by Clymb Clinical LLC. The CLYMB CLINICAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services for others in the field of tables, figures and listings (TFL) design, data planning, and implementation project management of clinical trials for the pharmaceutical and biotechnical industries
clymb clinical

General Information

Serial Number97627417
Word MarkCLYMB CLINICAL
Filing DateTuesday, October 11, 2022
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, July 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"CLINICAL"
Goods and ServicesConsulting services for others in the field of tables, figures and listings (TFL) design, data planning, and implementation project management of clinical trials for the pharmaceutical and biotechnical industries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 26, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameClymb Clinical LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBedford, MA 01730

Trademark Events

Event DateEvent Description
Friday, October 14, 2022NEW APPLICATION ENTERED
Wednesday, October 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 26, 2023ASSIGNED TO EXAMINER
Thursday, July 27, 2023NON-FINAL ACTION WRITTEN
Thursday, July 27, 2023NON-FINAL ACTION E-MAILED
Thursday, July 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, December 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 28, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, December 28, 2023PETITION TO REVIVE-GRANTED
Thursday, December 28, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, December 28, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, June 26, 2024ASSIGNED TO LIE
Thursday, June 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 29, 2025ASSIGNED TO EXAMINER
Thursday, July 10, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 10, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, July 10, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, July 10, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, July 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

clinical clymb management project implementation trials industries biotechnical pharmaceutical planning data